RE-SAMPLE - AI-POWERED CARE FOR PATIENTS WITH COPD AND OTHER CHRONIC ILLNESSES
English, sottotitoli in italiano, eestikeelsed subtiitrid

Nederlands

ABOUT RE-SAMPLE
See also CORDIS
Project information
Purpose project
Real-world data and AI to enable tailored-made care for patients with COPD and comorbid complex chronic conditions (CCCs)
Duration
01.03.2021 - 28.02.2025
Necessary funds
5 960 795.00 EURO
News
Year 1 Project Consortium meeting
First RE-SAMPLE Publication
RE-SAMPLE celebrates its first publication - "Digital Therapeutics: Virtual Coaching Powered by Artificial Intelligence on Real-World Data" by Harm op den Akker, Miriam Cabrita, and Aristodemos Pnevmatikakis (iSPRINT). In this article, partners from Innovation Sprint lay out their vision of Healthentia as a Digital Therapeutics platform, employing the RE-SAMPLE use case as a running example.
RE-SAMPLE PhD students at the Netherlands Respiratory Society 13th Young Investigator Symposium
Last year, RE-SAMPLE PhD students Charlotte Bucsán (MST, Enschede) and Sanne van Dijk (UT-HTSR, Enschede) joined the 13th Young Investigator Symposium (YIS) of the Netherlands Respiratory Society (NRS) in Amsterdam. The YIS was organised by the NRS Young Investigator Board, chaired by RE-SAMPLE’s clinical coordinator Anke Lenferink (UT-HTSR). The theme of the YIS was ‘Out of the box’.
RE-SAMPLE patient survey
The RE-SAMPLE project has launched a patient survey to learn from the patients who live with COPD about their experience, how they manage their disease, and where they would like more suppor: https://is.gd/resample.
Month 6 Project Consortium meeting
On 15 and 16 September 2021, the RE-SAMPLE Consortium convened online for the second time for a series of co-creation sessions, workshops, and presentations. The aim was to create a coherent vision of RE-SAMPLE components and outline the work of each partner for the next six months.